Sodium butyrate inhibits high glucose-induced inflammation by controlling the acetylation of NF-κB p65 in human monocytes
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: Hyperglycemia is a major cause of diabetes and diabetes-related diseases. Sodium butyrate (NaB) is a short-chain fatty acid derivative that produces dietary fiber by anaerobic bacterial fermentation in the large intestine and occurs in foods, such as Parmesan cheese and butter. Butyrate has been shown to prevent obesity, improve insulin sensitivity, and ameliorate dyslipidemia in diet-induced obese mice. Therefore, this study examined the effects and mechanism of NaB on the secretion of inflammatory cytokines induced by high glucose (HG) in THP-1 cells. MATERIALS/METHODS: THP-1 cells were used as an in vitro model for HG-induced inflammation. The cells were cultured under normal glycemic or hyperglycemic conditions with or without NaB (0–25 μM). Western blotting and quantitative polymerase chain reaction were used to evaluate the protein and mRNA levels of nuclear factor-κB (NF-κB), interleukin-6, tumor necrosis factor-α, acetylated p65, acetyl CREB-binding protein/p300 (CBP/p300), and p300 using THP-1 cells. Histone acetyltransferase (HAT), histone deacetylase (HDAC), and pro-inflammatory cytokine secretion activity were analyzed using an enzyme-linked immunosorbent assay. RESULTS: HG significantly upregulated histone acetylation, acetylation levels of p300, NF-κB activation, and inflammatory cytokine release in THP-1 cells. Conversely, the NaB treatment reduced cytokine release and NF-κB activation in HG-treated cells. It also significantly reduced p65 acetylation, CBP/p300 HAT activity, and CBP/p300 gene expression. In addition, NaB decreased the interaction of p300 in acetylated NF-κB and TNF-α. CONCLUSIONS: These results suggest that NaB suppresses HG-induced inflammatory cytokine production through HAT/HDAC regulation in monocytes. NaB has the potential for preventing and treating diabetes and its related complications.
Abstract
BACKGROUND/OBJECTIVES: Hyperglycemia is a major cause of diabetes and diabetes-related diseases. Sodium butyrate (NaB) is a short-chain fatty acid derivative that produces dietary fiber by anaerobic bacterial fermentation in the large intestine and occurs in foods, such as Parmesan cheese and butter. Butyrate has been shown to prevent obesity, improve insulin sensitivity, and ameliorate dyslipidemia in diet-induced obese mice. Therefore, this study examined the effects and mechanism of NaB on the secretion of inflammatory cytokines induced by high glucose (HG) in THP-1 cells. MATERIALS/METHODS: THP-1 cells were used as an in vitro model for HG-induced inflammation. The cells were cultured under normal glycemic or hyperglycemic conditions with or without NaB (0–25 μM). Western blotting and quantitative polymerase chain reaction were used to evaluate the protein and mRNA levels of nuclear factor-κB (NF-κB), interleukin-6, tumor necrosis factor-α, acetylated p65, acetyl CREB-binding protein/p300 (CBP/p300), and p300 using THP-1 cells. Histone acetyltransferase (HAT), histone deacetylase (HDAC), and pro-inflammatory cytokine secretion activity were analyzed using an enzyme-linked immunosorbent assay. RESULTS: HG significantly upregulated histone acetylation, acetylation levels of p300, NF-κB activation, and inflammatory cytokine release in THP-1 cells. Conversely, the NaB treatment reduced cytokine release and NF-κB activation in HG-treated cells. It also significantly reduced p65 acetylation, CBP/p300 HAT activity, and CBP/p300 gene expression. In addition, NaB decreased the interaction of p300 in acetylated NF-κB and TNF-α. CONCLUSIONS: These results suggest that NaB suppresses HG-induced inflammatory cytokine production through HAT/HDAC regulation in monocytes. NaB has the potential for preventing and treating diabetes and its related complications.
참고문헌 (26)
- Sun H, "IDF Diabetes Atlas : global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045", Diabetes Res Clin Pract, 183, pp.109119~ (2022)
- American Diabetes Association, "Diagnosis and classification of diabetes mellitus", Diabetes Care, 37(Suppl 1), pp.S81~S90 (2014)
- Kang JX, "Modulation of inflammatory cytokines by omega-3 fatty acids", Subcell Biochem, 49, pp.133~143 (2008)
- Varun Parkash Singh, "Advanced Glycation End Products and Diabetic Complications", The Korean Journal of Physiology & Pharmacology, 18(1), pp.1~14 (2014), 대한약리학회
- Jialal I, "Oxidative stress, inflammation, and diabetic vasculopathies : the role of alpha tocopherol therapy", Free Radic Res, 36, pp.1331~1336 (2002)
- Kim DY, "Myricitrin ameliorates hyperglycemia, glucose intolerance, hepatic steatosis, and inflammation in high-fat diet", streptozotocin-induced diabetic mice, 2020, pp.21, 1870~
- Guo Y, "Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-κB-mediated inflammation both in vitro and in vivo", Biochim Biophys Acta Mol Basis Dis, 1864, pp.238~251 (2018)
- Aryangat AV, "Type 2 diabetes : postprandial hyperglycemia and increased cardiovascular risk", Vasc Health Risk Manag, 6, pp.145~155 (2010)
- Nikiforov NG, "Pro-inflammatory monocyte polarization in type 2 diabetes mellitus and coronary heart disease", Vessel Plus, 1, pp.192~195 (2017)
- Tsalamandris S, "The role of inflammation in diabetes : current concepts and future perspectives", Eur Cardiol, 14, pp.50~59 (2019)
- 윤정미, "고혈당으로 유도된 염증반응 모델에서 유황양파즙의 항염증 효능 평가", 한국식품과학회지, 46(6), pp.773~777 (2014), 한국식품과학회[DOI]
- Yun JM, "Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin", J Nutr Biochem, 22, pp.450~458 (2011)
- Miao F, "In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions", J Biol Chem, 279, pp.18091~18097 (2004)
- Wegner M, "Role of epigenetic mechanisms in the development of chronic complications of diabetes", Diabetes Res Clin Pract, 105, pp.164~175 (2014)
- 이우제, "Gallic Acid Decreases Inflammatory Cytokine Secretion Through Histone Acetyltransferase", Histone Deacetylase Regulation in High Glucose-Induced Human Monocytes, 2015, pp.18(7), 793~801[DOI]
- Spange S, "Acetylation of non-histone proteins modulates cellular signalling at multiple levels", Int J Biochem Cell Biol, 41, pp.185~198 (2009)
- Kim HJ, "Fisetin inhibits hyperglycemia-induced proinflammatory cytokine production by epigenetic mechanisms", Evid Based Complement Alternat Med, 2012, pp.639469~ (2012)
- Shakespear MR, "Histone deacetylases as regulators of inflammation and immunity", Trends Immunol, 32, pp.335~343 (2011)
- Portela A, "Epigenetic modifications and human disease", Nat Biotechnol, 28, pp.1057~1068 (2010)
- Khullar M, "Emerging evidence of epigenetic modifications in vascular complication of diabetes", Front Endocrinol(Lausanne), 8, pp.237~ (2017)
- Pham TX, "Dietary regulation of histone acetylases and deacetylases for the prevention of metabolic diseases", Nutrients, 4, pp.1868~1886 (2012)
- Saldanha SN, "Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate", Exp Cell Res, 324, pp.40~53 (2014)
- Khan S, "Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38", ERK MAPK and apoptotic pathways : study in juvenile diabetic rat, 2014, pp.213, 1~12
- Ruderman NB, "Glucose and diabetic vascular disease", FASEB J, 6, pp.2905~2914 (1992)
- Ashburner BP, "The p65(RelA)subunit of NF-κB interacts with the histone deacetylase(HDAC)corepressors HDAC1 and HDAC2 to negatively regulate gene expression", Mol Cell Biol, 21, pp.7065~7077 (2001)
- Bierhaus A, "Diabetes-associated sustained activation of the transcription factor nuclear factor-κB", Diabetes, 50, pp.2792~2808 (2001)